New technology — created by Profs Robert Vince and Swati More from the Center for Drug Design — uses a camera to collect images of light interacting with the retina, which can show the early presence of Alzheimer’s Disease. Researchers and advocates hope the study, which just entered clinical trials, will shed light on the disease and medication design. Read full article on Minnesota Daily